Challenging times require great ambition to ensure better and sustainable healthcare for Europe's citizens. The EU Pharmaceutical Strategy aims to secure access to good quality healthcare, equity, and solidarity. The issue is whether the EU is bold and visionary enough to support a sustainable future for its life science industry and if life sciences in Europe are still part of the race for technology and innovation.